XML 61 R50.htm IDEA: XBRL DOCUMENT v3.25.0.1
Commercial Mortgage Loans, Subordinate Loans and Other Lending Assets, Net - Schedule of Loan Portfolio (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Financing Receivable, Allowance for Credit Loss [Line Items]    
Total loans, net $ 7,104,156 [1] $ 8,358,093
Financing Receivable, Held-for-Sale [2] 41,200  
Carrying value, net 7,145,356 8,358,093
Note receivable    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Financing Receivable, Held-for-Sale 41,200  
Commercial Mortgage Portfolio Segment    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Total loans, net [3],[4] 6,715,347 7,925,359
Subordinate Mortgage Portfolio Segment    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Total loans, net [4],[5] $ 388,809 $ 432,734
[1] Excludes Note receivable, held for sale with an outstanding principal and carrying value of $41.2 million.
[2] Related to our former Massachusetts Healthcare Loan, as defined and discussed in "Note 4 – Commercial Mortgage Loans, Subordinate Loans and Other Lending Assets, Net."
[3] Includes carrying value of $6,715,347 and $7,705,491 pledged as collateral under secured debt arrangements in 2024 and 2023, respectively.
[4] Net of $373,336 and $219,482 CECL Allowances comprised of $342,500 and $193,000 Specific CECL Allowance and $30,836 and $26,482 General CECL Allowance in 2024 and 2023, respectively.
[5] Includes carrying value of $232,991 as collateral under secured debt arrangements in 2023.